Introduction: Ebolaviruses cause severe viral hemorrhagic fever in humans and non-human
primates (NHPs), with case fatality rates of up to 90%. Currently, neither a specific treatment …

Over 40 years since the discovery of Ebola virus, the anti-Ebola virus vaccine efforts of the
past 2 decades have culminated in over 12 different vaccine candidates that have been …

The global outgoing outbreaks of Ebola virus disease (EVD) in different regions of Sudan,
Uganda, and Western Africa have brought into focus the inadequacies and restrictions of pre …

We have just witnessed the largest and most devastating outbreak of Ebola virus disease,
which highlighted the urgent need for development of an efficacious vaccine that could be …

Ebola is a viral illness of which the initial symptoms can include a sudden fever, intense
weakness, muscle pain and a sore throat, according to the World Health Organization …

Ebola virus infection causes severe hemorrhagic fevers with high fatality rates up to 90% in
humans, for which no effective treatment is currently available. The ongoing Ebola outbreak …

Ebola virus infection causes hemorrhagic fever with high mortality rates in humans and
nonhuman primates. Currently, there are no vaccines or therapies approved for human use …

Ebola Vaccine — An Urgent International Priority | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Ebola hemorrhagic fever is one of the most fatal viral diseases worldwide affecting humans
and nonhuman primates. Although infections only occur frequently in Central Africa, the …

Long-term control of viral outbreaks requires the use of vaccines to impart acquired
resistance and ensuing protection. In the wake of an epidemic, established immunity against …